Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice

Behavioural Brain Research

Volumn 113, Issue 1-2, 2000, Pages 65-72

  Gäddnäs, Helena ^a   Pietilä, Kirsi ^a   Ahtee, Liisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

5 Hydroxytryptamine; Dopamine; Locomotor activity; Nicotine; Noradrenaline; Withdrawal

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; BRAIN MONOAMINE; DOPAMINE; HOMOVANILLIC ACID; NICOTINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CHRONICITY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; DRUG WITHDRAWAL; HYPOTHALAMUS; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL;

ANIMALS; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NEUROTRANSMITTER AGENTS; NICOTINE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 0342756739     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00201-1     Document Type: Article

References (47)

1. Balfour D.J.K., Benwell M.E.M., Birrell C.E., Kelly R.J., Al-Aloul M. Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol. Biochem. Behav. 59:1998;1021-1030.
2. Balfour D.J.K., Fagerström K.O. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol. Ther. 72:1996;51-81.
3. Benwell M.E.M., Balfour D.J.K. The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol. 105:1992;849-856.
4. Benwell M.E.M., Balfour D.J.K., Birrell C.E. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br. J. Pharmacol. 114:1995;454-460.
5. Brioni J.D., Decker M.W., Sullivan J.P., Arneric S.J. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 37:1997;153-214.
6. Burn J.H., Truelove L.H., Burn I. The antidiuretic action of nicotine and of smoking. Br. Med. J. 1:1945;403-406.
7. Clarke P.B.S. Dopaminergic mechanisms in the locomotor stimulant effects of nicotine. Biochem. Pharmacol. 40:1990;1427-1432.
8. Clarke P.B.S., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78:1983;329-337.
9. Collins A.C., Miner L.L., Marks M.J. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol. Biochem. Behav. 30:1988;269-278.
10. Corrigall W.A., Coen K.M. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology. 99:1989;473-478.
11. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
12. File S. Recent developments in anxiety, stress and depression. Pharmacol. Biochem. Behav. 54:1996;3-12.
13. Fung Y.K., Schmid M.J., Anderson T.M., Lau Y. Effects of nicotine withdrawal on central dopaminergic systems. Pharmacol. Biochem. Behav. 53:1996;635-640.
14. Fuxe K., Everitt B.J., Hökfelt T. On the actions of nicotine and cotinine on central 5-hydroxytryptamine neurons. Pharmacol. Biochem. Behav. 10:1979;671-677.
15. Glassman A.H. Cigarette smoking: Implications for psychiatric illness. Am. J. Psychiatry. 150:1993;546-553.
16. Haikala H. Use of a novel type of rotating disc electrode and a flow cell with laminar flow pattern for the electrochemical detection of biogenic monoamines and their metabolites after Sephadex gel chromatographic purification and high-performance liquid chromatographic isolation from rat brain. J. Neurochem. 49:1987;1033-1041.
17. Hatchell P.C., Collins A.C. Influences of genotype and sex on behavioral tolerance to nicotine in mice. Pharmacol. Biochem. Behav. 6:1977;25-30.
18. Henningfield J.E., Goldberg S.R. Nicotine as a reinforer in human subjects and laboratory animals. Pharmacol. Biochem. Behav. 19:1983;989-992.
19. Hildebrand B.E., Nomikos G.G., Bondjers C., Nisell M., Svensson T.H. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology. 129:1997;348-356.
20. Hughes J.R., Gust S.W., Skoog K., Keenan R.M., Fenwick J.W. Symptoms of tobacco withdrawal. Arch. Gen. Psychiatry. 48:1991;52-59.
21. Hughes J.R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch. Gen. Psychiatry. 43:1986;289-294.
22. Ksir C., Hakan R.L., Kellar K.J. Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology. 92:1987;25-29.
23. Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci. Biobehav. Rev. 21:1997;91-104.
24. Malin D.H., Lake J.R., Newlin-Maultsby P., Roberts L.K., Lanier J.G., Carter V.A., Cunningham J.S., Wilson O.B. Rodent model of nicotine abstinence syndrome. Pharmacol. Biochem. Behav. 43:1992;779-784.
25. Marks M.J., Burch J.B., Collins A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226:1983;817-825.
26. Marks M.J., Stitzel J.A., Collins A.C. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J. Pharmacol. Exp. Ther. 235:1985;619-628.
27. Mitchell S.N., Smith K.M., Joseph M.H., Gray J.A. Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience. 56:1993;989-997.
28. Nordberg A., Wahlström G., Arnelo U., Larsson C. Effect of long-term nicotine treatment on [3H]-nicotine binding sites in the rats brain. Drug Alcohol Depend. 16:1985;9-17.
29. Nordberg A., Bergh C. Effect of nicotine on passive avoidance behaviour and motoric activity in mice. Acta Pharmacol. Toxicol. 56:1985;337-341.
30. Pekonen K., Karlsson C., Laakso I., Ahtee L. Plasma nicotine and cotinine concentrations in mice after chronic oral nicotine administration and challenge doses. Eur. J. Pharm. Sci. 1:1993;13-18.
31. Petersen D.R., Norris K.J., Thompson J.A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab. Dispos. 12:1984;725-731.
32. Peto R., Lopez A.D., Boreham J., Thun M., Heath C. Jr Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet. 339:1992;1268-1278.
33. Pietilä K., Lähde T., Attila M., Ahtee L., Nordberg A. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;176-182.
34. Pietilä K., Salminen O., Leikola-Pelho T., Ahtee L. Tolerance to nicotine's effects on striatal dopamine metabolism in nicotine-withdrawn mice. Eur. J. Pharmacol. 318:1996;17-22.
35. Pietilä K., Laakso I., Ahtee L. Chronic oral nicotine administration affects the circadian rhythm of dopamine and 5-hydroxytryptamine metabolism in the striata of mice. NaunynSchmiedeberg's Arch. Pharmacol. 353:1995;110-115.
36. Ribeiro E.B., Bettiker R.L., Bogdanov M., Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 621:1993;311-318.
37. Schwartz R.D., Kellar K.J. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science. 220:1983;214-216.
38. Smith K.M., Mitchell S.N., Joseph M.H. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaiminergic neurones in the rat brain. J. Neurochem. 57:1991;1750-1756.
39. Sparks J.A., Pauly J.R. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57B1/6 mice. Psychopharmacology. 141:1999;145-153.
40. Stolerman I.P., Fink R., Jarvik M.E. Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia. 30:1973;329-342.
41. Stolerman I.P., Jarvis M.J. The scientific case that nicotine is addictive. Psychopharmacology. 117:1995;2-10.
42. Stolerman I.P., Shoaib M. The neurobiology of tobacco addiction. Trends Pharmacol. Sci. 12:1991;467-473.
43. Swann A.C., Elsworth J.D., Charney D.S., Jablons D.M., Roth R.H., Redmond D.E. Jr, Maas J.W. Brain catecholamine metabolites and behavior in morphine withdrawal. Eur. J. Pharmacol. 86:1983;167-175.
44. Swedberg M.D.B., Henningfield J.E., Goldberg S.R. Nicotine dependency: animal studies. Wonnacott S., Russell M.A.H., Stolerman I.P. Nicotine Psychopharmacology. 1990;38-76 Oxford University Press, New York.
45. Takahashi H., Takada Y., Nagal N., Urano T., Takada A. Nicotine increases stress-induced serotonin release by stimulating nicotinic acetylcholine receptor in rat striatum. Synapse. 28:1998;212-219.
46. Tani Y., Saito K., Tsuneyoshi A., Imoto M., Ohno T. Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice. Psychopharmacology. 129:1997;225-232.
47. Welzl H., Alessandri B., Oettinger R., Bättig K. The effects of long-term nicotine treatment on locomotion, exploration and memory in young and old rats. Psychopharmacology. 96:1988;317-323.